title: Left ventricular mass index measured by quantitative gated myocardial SPECT with 99mTc-tetrofosmin: a comparison with echocardiography.
abstract: OBJECTIVE
  Left ventricular mass is an important determinant of diagnosis and prognosis in patients with heart disease. The aim of the present study was to validate measurement of the left ventricular mass index (LVMI) by quantitative gated myocardial SPECT (QGS) with 99mTc-tetrofosmin by comparing it with echocardiography.
  
  
  METHODS
  QGS and M-mode echocardiography (Echo) were performed within one month of each other in 179 patients. M-mode echocardiography was carried out according to Devereux's method. QGS images were acquired one hour after injection of 99Tc-tetrofosmin at rest. Myocardial volume was defined as the volume between the endocardial and epicardial surface in the end-diastolic phase. LVMI (g/m2) was defined as myocardial volume divided by myocardial specific density and corrected for body surface area. QGS LVMI measurements were performed twice by the same observer and independently by two different observers. Regional hypoperfusion in the group of patients with old myocardial infarction (n = 26) was evaluated semiquantitatively on the basis of the total defect score on the resting 99mTc-tetrofosmin SPECT images.
  
  
  RESULTS
  Among the patients as a whole QGS LVMI was significantly correlated with Echo LVMI (r = 0.96, p < 0.001). Intra-observer and inter-observer analyses showed significant reproducibility (r = 0.99 and r = 0.98, respectively, p < 0.001). In the patients with old myocardial infarction, but QGS LVMI was significantly lower than Echo LVMI (p < 0.001), and the magnitude of the underestimation was closely related to the severity of the perfusion defect on the resting SPECT images.
  
  
  CONCLUSIONS
  Measurements of LVMI by 99mTc-tetrofosmin QGS are reproducible and consistent with echocardiograpic estimates. Underestimation in patients with severe perfusion defects must be taken into consideration.
authors.affiliation: Department of Diagnostic Medicine (Nuclear Medicine and Tracer Kinetics), Osaka University Graduate School of Medicine, Suita, Japan.
authors.forename: Kaoru
authors.initials: K
authors.lastname: Maruyama
authors.forename: Shinji
authors.initials: S
authors.lastname: Hasegawa
authors.forename: Daisaku
authors.initials: D
authors.lastname: Nakatani
authors.forename: Asit Kr
authors.initials: AK
authors.lastname: Paul
authors.forename: Hideo
authors.initials: H
authors.lastname: Kusuoka
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Nishimura
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Hori
authors.forename: Jun
authors.initials: J
authors.lastname: Hatazawa
mesh_terms: D004452:Echocardiography / Q000379:methods; D005240:Feasibility Studies; D005260:Female; D015637:Gated Blood-Pool Imaging / Q000379:methods; D006331:Heart Diseases / Q000150:complications / Q000000981:diagnostic imaging* / Q000473:pathology; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015588:Observer Variation; D009929:Organ Size; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011859:Radiography; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000209:etiology / Q000473:pathology
chemical_list: D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin